Reunion Financial Statements From 2010 to 2024

REUNDelisted Stock  USD 1.12  0.01  0.90%   
Reunion Neuroscience financial statements provide useful quarterly and yearly information to potential Reunion Neuroscience investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Reunion Neuroscience financial statements helps investors assess Reunion Neuroscience's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Reunion Neuroscience's valuation are summarized below:
Reunion Neuroscience does not presently have any trending fundamental ratios for analysis.
Check Reunion Neuroscience financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Reunion Neuroscience's main balance sheet or income statement drivers, such as , as well as many indicators such as . Reunion financial statements analysis is a perfect complement when working with Reunion Neuroscience Valuation or Volatility modules.
  
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.

Reunion Neuroscience Company Return On Equity Analysis

Reunion Neuroscience's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Return On Equity

 = 

Net Income

Total Equity

More About Return On Equity | All Equity Analysis

Current Reunion Neuroscience Return On Equity

    
  -0.86  
Most of Reunion Neuroscience's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Reunion Neuroscience is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Competition

Based on the latest financial disclosure, Reunion Neuroscience has a Return On Equity of -0.8635. This is 96.4% lower than that of the Healthcare sector and 97.63% lower than that of the Biotechnology industry. The return on equity for all United States stocks is 178.55% higher than that of the company.

Reunion Neuroscience Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Reunion Neuroscience's current stock value. Our valuation model uses many indicators to compare Reunion Neuroscience value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Reunion Neuroscience competition to find correlations between indicators driving Reunion Neuroscience's intrinsic value. More Info.
Reunion Neuroscience is rated second in return on equity category among its peers. It is rated third in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Reunion Neuroscience's earnings, one of the primary drivers of an investment's value.

About Reunion Neuroscience Financial Statements

Reunion Neuroscience investors utilize fundamental indicators, such as revenue or net income, to predict how Reunion Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Field Trip Health Ltd. engages in the development and delivery of psychedelic- assisted therapies in North America. Field Trip Health Ltd. was founded in 2008 and is headquartered in Toronto, Canada. Reunion Neuroscience operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 194 people.

Pair Trading with Reunion Neuroscience

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Reunion Neuroscience position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Reunion Neuroscience will appreciate offsetting losses from the drop in the long position's value.

Moving against Reunion Stock

  0.89CMXHF CSL LimitedPairCorr
  0.88CSLLY CSLPairCorr
  0.87REGN Regeneron PharmaceuticalsPairCorr
  0.72NVO Novo Nordisk ASPairCorr
  0.71NONOF Novo Nordisk ASPairCorr
The ability to find closely correlated positions to Reunion Neuroscience could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Reunion Neuroscience when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Reunion Neuroscience - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Reunion Neuroscience to buy it.
The correlation of Reunion Neuroscience is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Reunion Neuroscience moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Reunion Neuroscience moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Reunion Neuroscience can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.
You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Other Consideration for investing in Reunion Stock

If you are still planning to invest in Reunion Neuroscience check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Reunion Neuroscience's history and understand the potential risks before investing.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Share Portfolio
Track or share privately all of your investments from the convenience of any device